Saxenda vs. Contrave: Uses, Side Effects and Dosing for Weight Loss
See how Saxenda and Contrave compare on approved uses, dosing, side effects, and cost.
Medically reviewed by Andre Stone | MD, University of Pittsburgh School of Medicine on September 9, 2026.
Key Takeaways
Saxenda fits adults and teens 12 to 17 who are fine with a daily GLP-1 injection and have no personal or family history of medullary thyroid cancer. Contrave fits adults who want a twice-daily pill that isn't a GLP-1. It isn't for people with seizures, uncontrolled blood pressure or opioid use.
Both drugs can cause nausea, constipation, and vomiting. Side-effect rates vary across studies and populations, so direct comparisons should be made cautiously.
Saxenda carries a boxed warning for thyroid C-cell tumors, while Contrave carries a boxed warning for suicidal thoughts tied to its bupropion component.
Saxenda vs. Contrave at a Glance
Saxenda
Contrave
| FEATURE | SAXENDA |
| Drug class | GLP-1 receptor agonist (liraglutide) |
| Form | Injection, once daily |
| Boxed warning | Thyroid C-cell tumors |
| Average weight loss in trials | 7.4% vs 3.0% on placebo over 56 weeks (label Study 1) |
| Generic | Generic liraglutide is available |
| FEATURE | CONTRAVE |
| Drug class | Opioid antagonist plus antidepressant (naltrexone/bupropion) |
| Form | Extended-release tablet, twice daily |
| Boxed warning | Suicidal thoughts and behaviors (bupropion) |
| Average weight loss in trials | May be less than with GLP-1 drugs |
| Generic | Sold as the brand Contrave |
Saxenda
| FEATURE | SAXENDA |
| Drug class | GLP-1 receptor agonist (liraglutide) |
| Form | Injection, once daily |
| Boxed warning | Thyroid C-cell tumors |
| Average weight loss in trials | 7.4% vs 3.0% on placebo over 56 weeks (label Study 1) |
| Generic | Generic liraglutide is available |
Contrave
| FEATURE | CONTRAVE |
| Drug class | Opioid antagonist plus antidepressant (naltrexone/bupropion) |
| Form | Extended-release tablet, twice daily |
| Boxed warning | Suicidal thoughts and behaviors (bupropion) |
| Average weight loss in trials | May be less than with GLP-1 drugs |
| Generic | Sold as the brand Contrave |
Saxenda vs. Contrave: How They Differ
Saxenda
Saxenda (liraglutide) is a GLP-1 receptor agonist used for chronic weight management in adults and teens ages 12 to 17 with obesity. It is given as a daily subcutaneous injection, with the dose raised gradually over about a month to a 3 mg maintenance level. A generic version of Saxenda (liraglutide) has been available since 2025 and usually costs less than the brand.
The Saxenda (liraglutide 3 mg) medication guide covers dosing and warnings.
Contrave
Contrave combines naltrexone, an opioid antagonist, with bupropion, an antidepressant, for chronic weight management in adults with obesity, or with overweight plus a weight-related condition. It is taken as an oral extended-release tablet, with the dose increased each week until it reaches the twice-daily maintenance level in week 4.
What Saxenda and Contrave Are Approved For
Saxenda
Saxenda is FDA-approved for chronic weight management in adults with obesity or overweight plus a weight-related condition, and in adolescents ages 12 to 17 with obesity. It works by mimicking the hormone GLP-1 to reduce appetite and slow digestion.
Adults with obesity or overweight plus a weight-related condition
Adolescents 12-17 with obesity
Not approved for diabetes treatment
Contraindicated with personal/family history of medullary thyroid carcinoma
Contrave
Contrave is FDA-approved for chronic weight management in adults with obesity or overweight plus a weight-related condition, used alongside a reduced-calorie diet and increased activity. It works through a different mechanism, pairing an opioid antagonist with an antidepressant to curb appetite and cravings.
Adults with obesity or overweight plus a weight-related condition
Must be combined with diet and exercise
Not approved for depression or other psychiatric disorders
Not approved for pediatric use
Saxenda vs. Contrave Side Effects
Saxenda
Contrave
Saxenda vs. Contrave Dosage
Saxenda
Contrave
| STAGE | DOSE | WHEN |
| Starting dose | 0.6 mg once daily | Week 1 |
| Maximum dose | 3 mg once daily | Week 5 onward |
| Dose changes | 4 increases | Every week |
| STAGE | DOSE | WHEN |
| Starting dose | 8 mg/90 mg once daily | Week 1 |
| Maximum dose | 2 tablets (16 mg/180 mg) twice daily, 32 mg/360 mg per day | Week 4 onward |
| Dose changes | 3 increases | Every week |
Saxenda
| STAGE | DOSE | WHEN |
| Starting dose | 0.6 mg once daily | Week 1 |
| Maximum dose | 3 mg once daily | Week 5 onward |
| Dose changes | 4 increases | Every week |
Contrave
| STAGE | DOSE | WHEN |
| Starting dose | 8 mg/90 mg once daily | Week 1 |
| Maximum dose | 2 tablets (16 mg/180 mg) twice daily, 32 mg/360 mg per day | Week 4 onward |
| Dose changes | 3 increases | Every week |
Saxenda vs. Contrave Pros, Cons and Cost
Saxenda
Saxenda has over a decade of clinical use as a weight-loss GLP-1 and a daily dosing schedule that allows gradual, flexible titration. It carries a boxed warning for thyroid tumors, and the brand's list price is higher than Contrave's.
Pros
Approved for adolescents 12-17 with obesity
Longest track record among GLP-1 weight-loss drugs, approved since 2014
Daily dosing allows finer control during titration
GLP-1 mechanism is often linked with greater average weight loss
Generic liraglutide (available since 2025) usually costs less than the brand
Cons
Requires a daily injection rather than a pill
Boxed warning for thyroid C-cell tumors
Brand list price roughly $1,300 to $1,350 per month without insurance, before savings programs
GI side effects like nausea tend to be more frequent
Contrave
Contrave is an oral non-GLP-1 option; oral GLP-1 pills for weight (Wegovy pill, Foundayo) are now also approved. If you'd choose Contrave only to avoid injections, those pills are worth asking about.
Contrave's list price is lower than brand Saxenda's. It carries its own boxed warning for suicidal thoughts tied to the bupropion component and has more contraindications related to seizures and blood pressure.
Pros
Oral tablet, no injections required
List price roughly $750 to $840 per month without insurance, before savings programs
No thyroid cancer boxed warning
Non-GLP-1 option for people who prefer to avoid GLP-1 drugs
Cons
Boxed warning for suicidal thoughts and behaviors from bupropion
Contraindicated with seizure history, uncontrolled hypertension, or opioid use
Not approved for adolescents
May produce less average weight loss than GLP-1 drugs
Frequently Asked Questions
Results
Which works better for weight loss, Saxenda or Contrave?
Saxenda is a GLP-1, and GLP-1s often lead to more average weight loss than Contrave, though results vary from person to person. Which fits you is a decision to make with a licensed doctor.
To see how Saxenda compares with a weekly GLP-1, read Saxenda vs Wegovy. To see how Contrave compares with GLP-1 drugs used for diabetes, read Ozempic vs Contrave and Contrave vs Trulicity.
Switching
Can you switch from Contrave to Saxenda?
Yes, people do switch, and you and a licensed doctor decide together when to stop Contrave and how to start Saxenda. Saxenda starts at 0.6 mg a day and goes up each week, so it takes about a month to reach 3 mg.
If you'd rather stay on a pill, the orforglipron (Foundayo) guide covers a daily GLP-1 tablet for weight. If Saxenda fits, you can get Saxenda online after a licensed doctor evaluates you.
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.